CompletedEarly Phase 1NCT05314153
Effects Zulresso on Postpartum Psychosis
Studying Postpartum psychosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of North Carolina, Chapel Hill
- Principal Investigator
- Samantha Meltzer-Brody, MD, MPH, MDUniversity of North Carolina, Chapel Hill
- Intervention
- Brexanolone(drug)
- Enrollment
- 10 target
- Eligibility
- 18-45 years · FEMALE
- Timeline
- 2022 – 2024
Study locations (1)
- UNC Hospitals, Chapel Hill, North Carolina, United States
Collaborators
Sage Therapeutics
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05314153 on ClinicalTrials.govOther trials for Postpartum psychosis
Additional recruiting or active studies for the same condition.